The Role of Quantitative Electroencephalogram in the Diagnosis and Subgrouping of Attention-Deficit/Hyperactivity Disorder.

Attention-deficit/hyperactivity disorder Child psychiatry Electrophysiology Subgroup Theta phase-gamma amplitude coupling Theta/beta ratio

Journal

Soa--ch'ongsonyon chongsin uihak = Journal of child & adolescent psychiatry

ISSN: 1225-729X

Titre abrégé: Soa Chongsonyon Chongsin Uihak

Pays: Korea (South)

ID NLM: 9440189

Informations de publication

Date de publication:
01 Jul 2021

Historique:

received: 16 04 2021

revised: 03 05 2021

accepted: 07 05 2021

entrez: 21 7 2021

pubmed: 22 7 2021

medline: 22 7 2021

Statut: ppublish

Résumé

Attention-deficit/hyperactivity disorder (ADHD) leads to functional decline in academic performance, interpersonal relationships, and development in school-aged children. Early diagnosis and appropriate intervention can significantly reduce the functional decline caused by ADHD. Currently, there is no established biological marker for ADHD. Some studies have suggested that various indicators from the quantitative electroencephalogram (QEEG) may be useful biological markers for the diagnosis of ADHD. Until the 2010s, theta/beta ratio (TBR) was a biomarker candidate for ADHD that consistently showed high diagnostic value. However, limitations of TBR have recently been reported. Studies have demonstrated that phase-amplitude coupling, especially theta phase-gamma amplitude coupling, are related to cognitive dysfunction and may assist in the diagnosis of ADHD. As yet, the underlying mechanism is not clearly established, and the clinical efficacy of these biomarkers needs to be proven through well-controlled studies. Based on the heterogeneous characteristics of ADHD, subgrouping through QEEG plays a key role in diagnosis and treatment planning. Sophisticated, well-designed studies and meta-analyses are necessary to confirm these findings.

Identifiants

DOI: 10.5765/jkacap.210010 PMID: 34285632 PMC: PMC8262972

pubmed: 34285632

doi: 10.5765/jkacap.210010

pii: jkacap-32-3-85

pmc: PMC8262972

doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

85-92

Informations de copyright

Déclaration de conflit d'intérêts

Conflicts of Interest The authors have no potential conflicts of interest to disclose.

Références

Biol Psychiatry. 2009 Aug 15;66(4):398-401

pubmed: 19500774

Neuroimage Clin. 2019;21:101601

pubmed: 30497980

J Am Acad Child Adolesc Psychiatry. 1990 Jul;29(4):546-57

pubmed: 2387789

Clin Neurophysiol. 2009 Oct;120(10):1806-11

pubmed: 19748828

Appl Psychophysiol Biofeedback. 2019 Jun;44(2):123-129

pubmed: 30604100

Front Psychol. 2012 Jun 13;3:195

pubmed: 22707946

J Child Psychol Psychiatry. 2010 Apr;51(4):368-89

pubmed: 20015192

Front Hum Neurosci. 2019 Dec 04;13:426

pubmed: 31866845

PLoS One. 2016 Aug 08;11(8):e0160697

pubmed: 27500640

J Child Psychol Psychiatry. 2016 Jun;57(6):770-1

pubmed: 27192956

Biol Psychiatry. 2020 Jul 1;88(1):103-110

pubmed: 31924323

Neuropsychopharmacology. 1998 Jul;19(1):1-9

pubmed: 9608571

J Child Psychol Psychiatry. 2018 Mar;59(3):223-231

pubmed: 28921526

J Am Acad Child Adolesc Psychiatry. 1996 Mar;35(3):343-51

pubmed: 8714323

Nord J Psychiatry. 2003;57(5):351-5

pubmed: 14522608

Psychiatry Res. 2008 Jun 30;159(3):346-58

pubmed: 18423617

J Child Psychol Psychiatry. 2016 May;57(5):656-8

pubmed: 27090383

Schizophr Res. 2020 Feb;216:154-160

pubmed: 31883931

Neurosci Biobehav Rev. 2012 Nov;36(10):2248-56

pubmed: 22922163

Proc Natl Acad Sci U S A. 2010 Feb 16;107(7):3228-33

pubmed: 20133762

Clin Neurophysiol. 2002 Feb;113(2):194-205

pubmed: 11856625

Neuropsychology. 1999 Jul;13(3):424-433

pubmed: 10447303

Neurosci Lett. 2015 Aug 31;603:25-30

pubmed: 26170246

J Clin Neurophysiol. 2007 Aug;24(4):348-51

pubmed: 17938604

J Abnorm Psychol. 2002 May;111(2):279-89

pubmed: 12003449

Hum Genet. 2009 Jul;126(1):51-90

pubmed: 19506906

J Clin Neurophysiol. 2006 Oct;23(5):440-55

pubmed: 17016156

J Psychiatr Res. 2010 Jan;44(2):90-8

pubmed: 19631948

J Atten Disord. 2013 Jul;17(5):374-83

pubmed: 23086616

J Atten Disord. 2013 Jul;17(5):384-92

pubmed: 23264365

Psychiatry Res. 2012 Aug 15;198(3):482-8

pubmed: 22425468

Clin Neurophysiol. 2019 Aug;130(8):1387-1396

pubmed: 31176621

Clin Neurophysiol. 2011 Jul;122(7):1333-41

pubmed: 21247797

Int J Neural Syst. 2019 Apr;29(3):1850046

pubmed: 30428723

Brain Behav. 2015 Apr;5(4):e00330

pubmed: 25798338

Psychiatry Res. 2014 May 30;216(3):391-7

pubmed: 24656956

Pediatr Neurol. 1992 Jan-Feb;8(1):30-6

pubmed: 1558573

Proc Natl Acad Sci U S A. 1999 Dec 21;96(26):15222-7

pubmed: 10611366

Psychiatry Res. 2001 Sep 20;103(2-3):205-18

pubmed: 11549408

PLoS One. 2020 Nov 17;15(11):e0242566

pubmed: 33201920

J Am Acad Child Adolesc Psychiatry. 2007 Dec;46(12):1605-13

pubmed: 18030082

Int J Psychophysiol. 2013 Sep;89(3):314-9

pubmed: 23619205

Lancet Psychiatry. 2018 Feb;5(2):175-186

pubmed: 29033005

Neurosci Lett. 2015 Mar 4;589:126-31

pubmed: 25595562

Can J Psychiatry. 2002 Aug;47(6):538-45

pubmed: 12211881

Front Hum Neurosci. 2021 Mar 26;15:622313

pubmed: 33841115

Biofeedback Self Regul. 1991 Sep;16(3):201-25

pubmed: 1932259

Psychiatry Res. 2018 Feb;260:406-411

pubmed: 29253805

Trends Cogn Sci. 2010 Nov;14(11):506-15

pubmed: 20932795

Neuroimage Clin. 2019;21:101600

pubmed: 30472167

Neuropsychiatry (London). 2013 Oct 1;3(5):455-458

pubmed: 24644516

Clin Neurophysiol. 2001 Nov;112(11):2098-105

pubmed: 11682348

Biol Psychiatry. 2009 Jan 1;65(1):46-54

pubmed: 19006789

PLoS One. 2016 Mar 01;11(3):e0145288

pubmed: 26930194